Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Buy
77
PRA Quote, Financials, Valuation and Earnings
Last price:
$23.18
Seasonality move
:
-1.58%
Day range:
$22.99 - $23.21
52-week range:
$10.76 - $23.29
Dividend yield:
0%
P/E ratio:
22.71x
P/S ratio:
1.05x
P/B ratio:
0.99x
Volume:
2.1M
Avg. volume:
878.1K
1-year change:
86.77%
Market cap:
$1.2B
Revenue:
$1.1B
EPS (TTM):
$1.02
Analysts' Opinion
-
Consensus RatingProAssurance has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $18.25, ProAssurance has an estimated downside of -21.2% from its current price of $23.16.
-
Price Target UpsideAccording to analysts, the highest upside price target is $20.00 representing -100% upside increase from its current price of $23.16.
Fair Value
-
According to the consensus of 4 analysts, ProAssurance has -21.2% downside to fair value with a price target of $18.25 per share.
PRA vs. S&P 500
-
Over the past 5 trading days, ProAssurance has overperformed the S&P 500 by 46.68% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
ProAssurance does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ProAssurance revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter ProAssurance reported revenues of $284.3M.
Earnings Growth
-
ProAssurance has grown year-over-year earnings for 1 quarter straight. In the most recent quarter ProAssurance reported earnings per share of $0.31.
Enterprise value:
-2.3B
EV / Invested capital:
--
Price / LTM sales:
1.05x
EV / EBIT:
-26.72x
EV / Revenue:
-2.02x
PEG ratio (5yr expected):
-0.03x
EV / Free cash flow:
115.67x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.94%
Net Income Margin (TTM):
4.68%
Return On Equity:
4.55%
Return On Invested Capital:
3.33%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1.1B | $1.1B | $295.6M | $284.3M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$0.01 | -$0.74 | $1.02 | $0.12 | $0.31 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.6B | $4.9B | $4.5B | $4.5B | $4.6B | |
| Total Assets | $4.7B | $6.2B | $5.7B | $5.6B | $5.6B | |
| Current Liabilities | $108.9M | $89.1M | $28.5M | $149M | $152.3M | |
| Total Liabilities | $3.3B | $4.8B | $4.6B | $4.5B | $4.4B | |
| Total Equity | $1.3B | $1.4B | $1.1B | $1.1B | $1.2B | |
| Total Debt | $284.7M | $425M | $427M | $427.1M | $424.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$29.8M | -$49.9M | -$10.7M | -$3.2M | -$238K | |
| Cash From Investing | -$62M | $141.1M | $10.7M | $3.8M | $16.4M | |
| Cash From Financing | -$21.8M | -$55.3M | -$11M | $3.2M | -$6.6M | |
| Free Cash Flow | -$34.2M | -$54.7M | -$19.7M | -$4.7M | -$2.6M | |
PRA
Sector
Market Cap
$1.2B
$616.2M
Price % of 52-Week High
99.44%
85.86%
Dividend Yield
0%
1.99%
Shareholder Yield
--
3.77%
1-Year Price Total Return
86.77%
8.45%
Beta (5-Year)
0.210
0.714
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$17.43
200-day SMA
Buy
Level
$14.48
Bollinger Bands (100)
Buy
Level
14.48 - 17.12
Chaikin Money Flow
Buy
Level
25.8M
20-day SMA
Buy
Level
$16.20
Relative Strength Index (RSI14)
Buy
Level
87.21
ADX Line
Buy
Level
26.55
Williams %R
Sell
Level
-1.4781
50-day SMA
Buy
Level
$15.43
MACD (12, 26)
Buy
Level
1.20
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
49.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6779)
Sell
CA Score
(Annual)
Level (-1.6657)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.4102)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
Stock Forecast FAQ
In the current month, PRA has received 0 Buy ratings 4 Hold ratings, and 0 Sell ratings. The PRA average analyst price target in the past 3 months is $18.25.
-
Where Will ProAssurance Stock Be In 1 Year?
According to analysts, the consensus estimate is that ProAssurance share price will drop to $18.25 per share over the next 12 months.
-
What Do Analysts Say About ProAssurance?
Analysts are divided on their view about ProAssurance share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ProAssurance is a Sell and believe this share price will rise from its current level to $17.00.
-
What Is ProAssurance's Price Target?
The price target for ProAssurance over the next 1-year time period is forecast to be $18.25 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is PRA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ProAssurance is a Hold. 4 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of PRA?
You can purchase shares of ProAssurance via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ProAssurance shares.
-
What Is The ProAssurance Share Price Today?
ProAssurance was last trading at $23.18 per share. This represents the most recent stock quote for ProAssurance. Yesterday, ProAssurance closed at $23.16 per share.
-
How To Buy ProAssurance Stock Online?
In order to purchase ProAssurance stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
